MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-PY-03-0009041
Medigrand Pharmaceuticals Private Limited - pharma in Harur, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹1.34 Cr
▲ 43% YoY
Net loss · FY 2022
₹62.11 Lakh
Net margin -46.5%
EBITDA · FY 2022
₹2.37 Lakh
EBITDA margin 1.8%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Open charges
₹7.23 Cr
Satisfied ₹3.47 Cr
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
About Medigrand Pharmaceuticals Private Limited
Data last updated:
Medigrand Pharmaceuticals Private Limited is a private limited company based in Harur, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 July 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24297TN2011PTC081348. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It was formerly known as Baksen Pharmaceuticals Private Limited. It is led by directors including Narasimman Suresh (Managing Director) and Ayyakannu Sivakumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 46/2A Vishnu Plaza Thirupattur Main Road Kurinji Nagar Harur Taluk, Tamil Nadu, India – 636903.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.34 Cr, a growth of 43% compared to the previous year. For the same year it recorded a net loss of ₹62.11 Lakh (net margin -46.5%) and EBITDA of ₹2.37 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 83% over five years.
The company is associated with 1 brand: MediGrand. As per MCA filings, the company has open charges of ₹7.23 Cr and satisfied charges of ₹3.47 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
Medigrand Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PY-03-0009041). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medigrandpharma.com.
Company details
CIN U24297TN2011PTC081348
Registration Number 081348
Incorporation Date 04 July 2011
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-PY-03-0009041
Key People
Narasimman Suresh Managing Director Ayyakannu Sivakumar Director Muthamilan Vivekanandhan Director Recognitions & Rankings of Medigrand Pharmaceuticals
Contact details
Medigrand Pharmaceuticals Private Limited's registered office is in Harur, Tamil Nadu. Its website is medigrandpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address46/2A Vishnu Plaza Thirupattur Main Road Kurinji Nagar Harur Taluk, Tamil Nadu, India – 636903
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medigrand Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Medigrand Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Medigrand Pharmaceuticals operates one associated brand: MediGrand. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing for human and veterinary healthcare in India. | medigrandpharma.com |
Business activity
The main business activity of Medigrand Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medigrand Pharmaceuticals Private Limited, buy the company report.
Financials of Medigrand Pharmaceuticals Private Limited
FY 2025 filings availableMedigrand Pharmaceuticals Private Limited reported revenue of ₹1.34 Cr (up 43% YoY) for FY 2022.
Revenue · FY 2022
₹1.34 Cr ▲ 43%
Net loss · FY 2022
₹62.11 Lakh margin -46.5%
EBITDA · FY 2022
₹2.37 Lakh margin 1.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 30%
5 years · compounded
▲ 83%
EBITDA CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 31%
5 years · compounded
▲ 125%
Revenue has grown at a compounded annual rate (CAGR) of 83% over five years, including 43% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.34 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.37 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹62.11 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | -46.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medigrand Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medigrand Pharmaceuticals Private Limited
Medigrand Pharmaceuticals has 3 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ayyakannu Sivakumar | Director | 30 Nov 2021 | 4 Years 11 Months | Current |
| Narasimman Suresh | Managing Director | 06 Jul 2022 | 4 Years 3 Months | Current |
| Muthamilan Vivekanandhan | Director | 30 Nov 2021 | 4 Years 11 Months | Current |
Peer comparison
Medigrand Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Riocure Pharmaceuticals Private Limited | ₹1.34 Cr (FY 2024) | 2.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Medigrand Pharmaceuticals Private Limitedthis company | ₹1.34 Cr (FY 2022) | -₹62.11 Lakh | -46.5% | 43.0% | Harur, Tamil Nadu, India | |
| Anabolic Remedies Private Limited | ₹1.34 Cr (FY 2025) | -7.0% | Chandigarh, India | |||
| Nature Pure Supercritical Extracts Private Limited | ₹1.34 Cr (FY 2024) | -56.0% | Mumbai, Maharashtra, India | |||
| Mimulus Laboratories Private Limited | ₹1.33 Cr (FY 2025) | 1223.0% | Puducherry, India |
To see the full peer comparison of Medigrand Pharmaceuticals Private Limited, buy the company report.
Auditor
Medigrand Pharmaceuticals Private Limited is audited by RAMACHANDRAN JITHENDIRAN & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMACHANDRAN JITHENDIRAN & CO | FY 2022 | 010042S |
Shareholding
The shareholding of Medigrand Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medigrand Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7.23 Cr
Satisfied charges
₹3.47 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Feb 2026 | 101227627 | Sidbi | ₹1.6 Cr | Open | |
| 25 Sep 2025 | 101158634 | Sidbi | ₹74.5 Lakh | Open | |
| 03 Jul 2024 | 100953696 | State Bank of India | ₹4.88 Cr | Open | |
| 31 Jan 2024 | 100860508 | Indian Bank | ₹22 Lakh | Satisfied | |
| 27 Dec 2016 | 100079661 | Others | ₹3.25 Cr | Satisfied |
To see the full charge records of Medigrand Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Medigrand Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Medigrand Pharmaceuticals. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Puducherry | Civil suit | Filed by the company against Sattyavel Construction Rep by Its Proprietor | Disposed |
To see the full case history of Medigrand Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medigrand Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medigrand Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 30, 2024.
Active EPFO establishments
1
GST
Medigrand Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Medigrand Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medigrand Pharmaceuticals Private Limited has 17 board changes on record since 2020: 3 appointments and 14 cessations. The latest: Ponnusamy Ponmathi ceased to be Additional Director on 27 Mar 2023.
Charges
A charge with Sidbi amounted to Rs. 1.60 Cr with Charge ID 101227627 was registered on 03 Feb 2026.
Charges
A charge with State Bank Of India of Rs. 4.88 Cr registered on 03 Jul 2024 with Charge ID 100953696 was modified on 25 Nov 2025.
AGM
Medigrand Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Sidbi amounted to Rs. 0.75 Cr with Charge ID 101158634 was registered on 25 Sep 2025.
Filing
Medigrand Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with State Bank Of India amounted to Rs. 4.88 Cr with Charge ID 100953696 was registered on 03 Jul 2024.
Charges
A charge registered on 31 Jan 2024 via Charge ID 100860508 with Indian Bank was fully satisfied on 06 Mar 2024.
Charges
A charge with Indian Bank amounted to Rs. 0.22 Cr with Charge ID 100860508 was registered on 31 Jan 2024.
Ceased
Ponnusamy Ponmathi ceased to be Additional Director.
Ceased
Rajan Ramesh ceased to be Director.
Appointed
Narasimman Suresh was appointed as Managing Director.
Charges
A charge registered on 27 Dec 2016 via Charge ID 100079661 with Others was fully satisfied on 05 Mar 2022.
16 earlier events are in the company report.
Frequently asked questions
Medigrand Pharmaceuticals is an active private limited company based in Harur, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 July 2011 (15+ years old) and is registered under CIN U24297TN2011PTC081348.
Medigrand Pharmaceuticals has 3 current directors:
- Narasimman Suresh - Managing Director
- Ayyakannu Sivakumar - Director
- Muthamilan Vivekanandhan - Director
The latest financial statements of Medigrand Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Medigrand Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Medigrand Pharmaceuticals is U24297TN2011PTC081348. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medigrand Pharmaceuticals has 1 court case on record: 1 filed by the company.
Medigrand Pharmaceuticals was incorporated on 04 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Medigrand Pharmaceuticals by revenue are Riocure Pharmaceuticals Private Limited, Anabolic Remedies Private Limited, Nature Pure Supercritical Extracts Private Limited, Mimulus Laboratories Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ponnusamy Ponmathi ceased to be Additional Director on 27 Mar 2023. Rajan Ramesh ceased to be Director on 27 Mar 2023. Narasimman Suresh was appointed as Managing Director on 06 Jul 2022. Medigrand Pharmaceuticals has 17 board changes on record in total.
Yes, Medigrand Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-PY-03-0009041).
Medigrand Pharmaceuticals can be reached through the website medigrandpharma.com. Its registered office is in Harur, Tamil Nadu, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages